Fusen Pharmaceutical Company Limited (HKG:1652)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.110
+0.040 (3.74%)
At close: Mar 10, 2026

Fusen Pharmaceutical Company Company Description

Fusen Pharmaceutical Company Limited, an investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China.

The company’s product portfolio includes Shuanghuanglian oral solutions and Shuanghuanglian injections; Sanhuang tablet; heat-clearing and detoxicating oral solutions; nicardipine hydrochloride injections; and other products.

It also offers small and large volume injections, oral liquids, tablets, capsules, granules, traditional Chinese medicine extracts, and chemical synthesis.

In addition, the company provides business management and consulting services; and engages in the sale of construction material and electricity.

It offers its medicines for the treatment of heat-clearing and detoxification, cardiovascular and cerebrovascular, antihypertensive and hypoglycemic, tonifying, qi-regulating, anti-anemia, and antibacterial and anti-inflammatory.

Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.

Fusen Pharmaceutical Company Limited
Country Cayman Islands
Founded 2003
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,045
CEO Zhiming Cao

Contact Details

Address:
Urban Industrial Zone
Nanyang
China
Website fusenyy.com

Stock Details

Ticker Symbol 1652
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number KYG370981030
SIC Code 2834

Key Executives

Name Position
Zhiming Cao Chief Executive Officer and Executive Chairman
Taisheng Hou Executive Director
Yongsheng Chi Executive Director
Qingfen Meng Executive Director
Zhen Li Chief Financial Officer
Yuk Hong Yeung Company Secretary